the use of human herpesvirus 6 or derivatives thereof for the manufacture of a pharmaceutical composition for the prevention of atopi or atopic disease, including asthma in children

摘要

The present invention discloses a use of human herpes virus 6 (HHV-6) or derivatives thereof, for the manufacture of a pharmaceutical composition intended to be administered during early childhood, for the prevention of IgE sensitization and allergy development in young children. Examples of viral compositions include, but are not limited to live human herpes virus 6 (HHV-6).